臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pei jer chen"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 466-515 / 883 (共18页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-07-03T03:34:26Z	Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3	Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:26Z	Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy	Sheng W.-H.; Hung C.-C.; Chang S.-Y.; Liu C.-J.; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; PEI-JER CHEN; Chang S.-C.
臺大學術典藏	2021-07-03T03:34:25Z	Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation	Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:25Z	Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis	Jiang S.; Yang Z.; Li W.; Li X.; Wang Y.; Zhang J.; Xu C.; PEI-JER CHEN; Hou J.; McCrae M.A.; Chen X.; Zhuang H.; Lu F.
臺大學術典藏	2021-07-03T03:34:25Z	Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia	Afdhal N.H.; Giannini E.G.; Tayyab G.; Mohsin A.; Lee J.-W.; Andriulli A.; Jeffers L.; McHutchison J.; PEI-JER CHEN; Han K.-H.; Campbell F.; Hyde D.; Brainsky A.; Theodore D.
臺大學術典藏	2021-07-03T03:34:25Z	Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells	Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:24Z	IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients	Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:24Z	A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma	Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Yuan S.-S.; Shih J.-N.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:24Z	Influences of tobacco and alcohol use on hepatocellular carcinoma survival	Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Liu C.-J.; Lin C.-L.; Yu M.-W.
臺大學術典藏	2021-07-03T03:34:23Z	Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells	Tai W.-T.; Shiau C.-W.; Chen H.-L.; Liu C.-Y.; Lin C.-S.; Cheng A.-L.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:23Z	Predicting clinical outcome in a patient with chronic hepatitis B virus infection	Yang H.-I.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:23Z	Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy	Huang Y.-W.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Huang S.-H.; Chen D.-S.; PEI-JER CHEN; Hsu P.-N.; Yang S.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:23Z	Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia	Chen D.-S.; Locarnini S.; Wait S.; Bae S.-H.; PEI-JER CHEN; Fung J.Y.Y.; Kim H.S.; Lu S.-N.; Sung J.; Tanaka J.; Wakita T.; Ward J.; Wallace J.
臺大學術典藏	2021-07-03T03:34:22Z	Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.	Huang T.S.; Shyu Y.C.; Turner R.; Chen H.Y.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:22Z	Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody	Chen K.-F.; Chen H.-L.; Shiau C.-W.; Liu C.-Y.; Chu P.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:22Z	A real-time convective PCR machine in a capillary tube instrumented with a CCD-based fluorometer	Hsieh Y.-F.; Lee D.-S.; Chen P.-H.; Liao S.-K.; Yeh S.-H.; PEI-JER CHEN; Yang A.-S.
臺大學術典藏	2021-07-03T03:34:22Z	Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management	Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:21Z	Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses	Tzeng H.-T.; Hsu P.-N.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:21Z	Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients	Yuan Q.; Song L.-W.; Liu C.-J.; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN; Xia N.-S.
臺大學術典藏	2021-07-03T03:34:21Z	Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion	Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:20Z	Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up	Yu M.-L.; Lee C.-M.; Chen C.-L.; Chuang W.-L.; Lu S.-N.; Liu C.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Kao J.-H.; Su W.-W.; Lin C.-L.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-07-03T03:34:20Z	Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:20Z	Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: The emerging role for radioembolization using yttrium-90	Lau W.-Y.; Sangro B.; PEI-JER CHEN; Cheng S.-Q.; Chow P.; Lee R.-C.; Leung T.; Han K.-H.; Poon R.T.P.
臺大學術典藏	2021-07-03T03:34:19Z	Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity	Chen Y.; Li C.; He D.; Cheng T.; Ge S.; Shih J.W.K.; Zhao Q.; PEI-JER CHEN; Zhang J.; Xia N.
臺大學術典藏	2021-07-03T03:34:19Z	Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)	Park J.-W.; Amarapurkar D.; Chao Y.; PEI-JER CHEN; Geschwind J.-F.H.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:19Z	Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention	Wen W.-H.; Chang M.-H.; Zhao L.-L.; Ni Y.-H.; Hsu H.-Y.; Wu J.-F.; PEI-JER CHEN; Chen D.-S.; Chen H.-L.
臺大學術典藏	2021-07-03T03:34:19Z	Selenium for sepsis: What have we learned so far?	Huang T.-S.; Shyu Y.-C.; Yuan S.-S.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:18Z	Effect of Parenteral Selenium Supplementation in Critically Ill Patients: A Systematic Review and Meta-Analysis	Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Lin L.-M.; Lo C.-Y.; Yuan S.-S.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:18Z	Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma	Toh H.C.; PEI-JER CHEN; Carr B.I.; Knox J.J.; Gill S.; Ansell P.; McKeegan E.M.; Dowell B.; Pedersen M.; Qin Q.; Qian J.; Scappaticci F.A.; Ricker J.L.; Carlson D.M.; Yong W.P.
臺大學術典藏	2021-07-03T03:34:18Z	One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor	PEI-JER CHEN; Wu T.-C.
臺大學術典藏	2021-07-03T03:34:17Z	Application of Massively Parallel Sequencing to Genetic Diagnosis in Multiplex Families with Idiopathic Sensorineural Hearing Impairment	Wu C.-C.; Lin Y.-H.; Lu Y.-C.; PEI-JER CHEN; Yang W.-S.; Hsu C.-J.; Chen P.-L.
臺大學術典藏	2021-07-03T03:34:17Z	Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence [2]	Yeh Y.-C.; PEI-JER CHEN; Lai M.-S.
臺大學術典藏	2021-07-03T03:34:17Z	Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection	Su T.-H.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:16Z	Liver sinusoidal endothelial cell lectin inhibits CTL-dependent virus clearance in mouse models of viral hepatitis	Liu B.; Wang M.; Wang X.; Zhao D.; Liu D.; Liu J.; PEI-JER CHEN; Yang D.; He F.; Tang L.
臺大學術典藏	2021-07-03T03:34:16Z	Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant	Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Jeng Y.-M.; Chiang C.-L.; Chen H.-L.; Wu J.-F.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:16Z	Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice	Lin W.-H.; Yeh S.-H.; Yang W.-J.; Yeh K.-H.; Fujiwara T.; Nii A.; Chang S.S.-C.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:16Z	Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients	Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:15Z	Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan	Lee J.-T.; Shao P.-L.; Chang L.-Y.; Xia N.-S.; PEI-JER CHEN; Lu C.-Y.; Huang L.-M.
臺大學術典藏	2021-07-03T03:34:15Z	Polymerase chain reaction with phase change as intrinsic thermal control	Hsieh Y.-F.; Yonezawa E.; Kuo L.-S.; Yeh S.-H.; PEI-JER CHEN; Chen P.-H.
臺大學術典藏	2021-07-03T03:34:15Z	Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:15Z	Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C	Su T.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:14Z	ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers	Liu W.-H.; Chen C.-H.; Yeh K.-H.; Li C.-L.; Wu Y.-J.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏	2021-07-03T03:34:14Z	Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel	Cheng A.L.; Amarapurkar D.; Chao Y.; PEI-JER CHEN; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W.
臺大學術典藏	2021-07-03T03:34:14Z	Reduction of HBV replication prolongs the early immunological response to IFNα therapy	Tan A.T.; Hoang L.T.; Chin D.; Rasmussen E.; Lopatin U.; Hart S.; Bitter H.; Chu T.; Gruenbaum L.; Ravindran P.; Zhong H.; Gane E.; Lim S.G.; Chow W.C.; PEI-JER CHEN; Petric R.; Bertoletti A.; Hibberd M.L.
臺大學術典藏	2021-07-03T03:34:14Z	Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:13Z	SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model	Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:13Z	Eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis, allowing for effective antiviral therapy	Afdhal N.H.; Dusheiko G.M.; Giannini E.G.; PEI-JER CHEN; Han K.-H.; Mohsin A.; Rodriguez-Torres M.; Rugina S.; Bakulin I.; Lawitz E.; Shiffman M.L.; Tayyab G.-U.-N.; Poordad F.; Kamel Y.M.; Brainsky A.; Geib J.; Vasey S.Y.; Patwardhan R.; Campbell F.M.; Theodore D.
臺大學術典藏	2021-07-03T03:34:12Z	Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection	Liu C.-J.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:12Z	Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma	Tai W.-T.; Shiau C.-W.; PEI-JER CHEN; Chu P.-Y.; Huang H.-P.; Liu C.-Y.; Huang J.-W.; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:12Z	Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality	Liu C.-J.; Chu Y.-T.; Shau W.-Y.; Kuo R.N.; PEI-JER CHEN; Lai M.-S.

显示项目 466-515 / 883 (共18页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :2822924
	造访人次 : 30031860 在线人数 : 1194 教育部委托研究计画计画执行:国立台湾大学图书馆